Clinical trials
Completed Phase 1 Non-alcoholic Fatty Liver Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
116 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 13 |
| 2019 | 8 |
| 2020 | 16 |
| 2021 | 20 |
| 2022 | 6 |
| 2023 | 20 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 116 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 9 |
| AstraZeneca | 7 |
| Novo Nordisk A/S | 6 |
| Corcept Therapeutics | 5 |
| Altimmune, Inc. | 4 |
| Enanta Pharmaceuticals, Inc | 4 |
| Bristol-Myers Squibb | 3 |
| Columbia University | 3 |
| Gannex Pharma Co., Ltd. | 3 |
| Gilead Sciences | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 116 |
| Obesity | 13 |
| Fatty Liver | 6 |
| Diabetes Mellitus | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Overweight | 5 |
| Liver Cirrhosis | 4 |
| Liver Diseases | 4 |
| Dyslipidemias | 3 |
| Fibrosis | 3 |
Trials
Showing 1 to 25 of 116. Each trial links to its page on Pharma Observatory.
16 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.